Pyc8.0

Pycnogenol

Pycnogenol (French Maritime Pine Bark)

Patented pine bark extract with over 400 studies supporting benefits for circulation, skin, cognitive function, and joint health.

immunitycognitioncirculationskin healthcognitivejoint health
Last reviewed: January 1, 2025
8.0/10
40+ studies
Evidence
high
Safety
50-200mg
Dose
4-12 weeks
Time to Effect
Pycnogenol brand (standardized to 65-75% procyanidins)
Best Form

Pycnogenol is a standardized extract from French maritime pine bark, rich in procyanidins similar to grape seed. It's one of the most researched botanical supplements with over 400 published studies. Evidence supports benefits for circulation, venous insufficiency, skin health, cognitive function, ADHD, and joint mobility.

Mechanisms of Action

🔄
Endothelial Function

Supports blood vessel health

✨
Collagen Binding

Binds to and protects collagen and elastin

🛡️
Antioxidant

Powerful free radical scavenging

Recommended Dose

50-200mg

50mg300mg

Optimal Timing

  • With meals

Take with food

Best Form

Pycnogenol brand (standardized to 65-75% procyanidins)

Alternatives: Generic pine bark extract

Pycnogenol is a specific patented extract with the most research. Generic pine bark may vary in composition.

Duration

Minimum: 4 weeks

Optimal: 12 weeks

Cycling: Not required

Note: Can be taken any time. Often split into 2 doses.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🔄
Improved Circulation

Better blood flow and reduced edema

4-8 weeks
65% of users notice thispositive
🧠
Cognitive Function

Improved attention and memory

4-8 weeks
55% of users notice thispositive
✨
Skin Health

Improved skin elasticity and hydration

6-12 weeks
55% of users notice thispositive
High SafetyMax safe dose: Up to 450mg/day used in studies
🔴
Pregnant/nursing

Limited data; avoid unless advised

🟡
Children

Some studies in ADHD children; use under medical guidance

Who Should NOT Take This

  • Pine allergy

Drug Interactions

Blood thinnersmild

May have mild antiplatelet effects — may affect platelet aggregation or vitamin K-dependent clotting factors, altering anticoagulant efficacy

Immunosuppressantsmild

May have immune-modulating effects

Diabetes medicationsmild

May have blood sugar lowering effects

Possible Side Effects

GI upsetuncommon

Tip: Take with food

Headacheuncommon

Tip: Usually resolves

Dizzinessrare

Tip: Reduce dose

Warnings

  • Expensive compared to alternatives
  • May affect blood clotting — stop before surgery

Top studies from 40+ peer-reviewed papers

meta-analysisn=7690
DOI

Martinez-Zapata MJ et al. • The Cochrane database of systematic reviews (2020)

“There is moderate-certainty evidence that phlebotonics probably reduce oedema slightly, compared to placebo; moderate-certainty evidence of little or no difference in QoL; and low-certainty evidence that these drugs do not influence ulcer healing.”
Key Findings:
  • Pooled data suggest that phlebotonics probably increase adverse events slightly, compared to placebo (RR 1.14, 95% CI 1.02 to 1.27; 37 studies; 5789 participants; moderate-certainty evidence).
  • There is moderate-certainty evidence that phlebotonics probably reduce oedema slightly, compared to placebo; moderate-certainty evidence of little or no difference in QoL; and low-certainty evidence that these drugs do not influence ulcer healing.
  • Moderate-certainty evidence suggests that phlebotonics are probably associated with a higher risk of adverse events than placebo.
  • Studies included in this systematic review provided only short-term safety data; therefore, the medium- and long-term safety of phlebotonics could not be estimated.
meta-analysisn=1641
DOI

Robertson NU et al. • The Cochrane database of systematic reviews (2020)

“Small sample sizes, limited numbers of RCTs per condition, variation in outcome measures, and poor reporting of the included RCTs mean no definitive conclusions regarding the efficacy or safety of pine bark extract supplements are possible.”
Key Findings:
  • In a mixed group of participants with type 1 and type 2 DM we do not know whether pine bark extract decreases HbA1c (MD -0.20 %, 95% CI -1.83 to 1.43; one study; 67 participants; very low-certainty evidence).
  • We do not know whether pine bark extract increases bone alkaline phosphatase in post-menopausal women with osteopenia (MD 1.16 ug/L, 95% CI -2.37 to 4.69; one study; 40 participants; very low-certainty evidence).
  • Small sample sizes, limited numbers of RCTs per condition, variation in outcome measures, and poor reporting of the included RCTs mean no definitive conclusions regarding the efficacy or safety of pine bark extract supplements are possible.
meta-analysisn=922
DOI

Pourmasoumi M et al. • Phytotherapy research : PTR (2020)

“Further, high quality randomized clinical trials are needed to confirm this result.© 2019 John Wiley & Sons, Ltd.”
Key Findings:
  • Pooled analysis suggested that pycnogenol supplementation can reduced systolic blood pressure (SBP) of (-3.22 mmHg; 95% CI [-5.52, -0.92]) and diastolic blood pressure (DBP; -1.91 mmHg; 95% CI [-3.64, -0.18]).
  • Effect of pycnogenol on SBP was more pronounce in subgroup in which pycnogenol was administered along with other treatments.
  • A significant effect of pycnogenol on DBP in studies with >12-week duration, whereas this favorable effect was not observed in subgroup with ≤12-week supplementation.
  • The present systematic review and meta-analysis suggest that pycnogenol had a favorable effect on SBP and DBP.
meta-analysisn=1065
DOI

Hadi A et al. • Phytotherapy research : PTR (2019)

“Since there are few phytochemicals that have a significant increasing effect on HDL-C levels, pycnogenol may have important role in prevention of cardiovascular diseases.© 2018 John Wiley & Sons, Ltd.”
Key Findings:
  • To estimate the effect size, changes in blood lipids were implemented.
  • A systematic review and meta-analysis of 14 clinical trials with 1,065 participants suggested a significant increase in plasma concentration of high density lipoprotein cholesterol (HDL-C; 3.27 mg/dL; 95% CI [0.19, 6.36]; p = 0.038).
  • Since there are few phytochemicals that have a significant increasing effect on HDL-C levels, pycnogenol may have important role in prevention of cardiovascular diseases.© 2018 John Wiley & Sons, Ltd.
meta-analysisn=791
DOI

Schoonees A et al. • The Cochrane database of systematic reviews (2012)

“Current evidence is insufficient to support Pycnogenol(®) use for the treatment of any chronic disorder.”
Key Findings:
  • Current evidence is insufficient to support Pycnogenol(®) use for the treatment of any chronic disorder.
  • Well-designed, adequately powered trials are needed to establish the value of this treatment.
  • Further research warranted to confirm findings
39
Total Studies
9.0/10
Avg Quality
10-7,690
Sample Size Range
2005-2025
Research Span

Study Type Distribution

Meta-Analysis
19
RCT
14
Systematic Review
5
Crossover
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.